1. Home
  2. BHIL vs UBX Comparison

BHIL vs UBX Comparison

Compare BHIL & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHIL
  • UBX
  • Stock Information
  • Founded
  • BHIL 2012
  • UBX 2009
  • Country
  • BHIL United States
  • UBX United States
  • Employees
  • BHIL N/A
  • UBX N/A
  • Industry
  • BHIL Packaged Foods
  • UBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BHIL Consumer Staples
  • UBX Health Care
  • Exchange
  • BHIL Nasdaq
  • UBX Nasdaq
  • Market Cap
  • BHIL 27.1M
  • UBX 24.6M
  • IPO Year
  • BHIL N/A
  • UBX 2018
  • Fundamental
  • Price
  • BHIL $2.69
  • UBX $0.96
  • Analyst Decision
  • BHIL
  • UBX Strong Buy
  • Analyst Count
  • BHIL 0
  • UBX 1
  • Target Price
  • BHIL N/A
  • UBX $8.00
  • AVG Volume (30 Days)
  • BHIL 35.4K
  • UBX 93.3K
  • Earning Date
  • BHIL 11-12-2024
  • UBX 11-04-2024
  • Dividend Yield
  • BHIL N/A
  • UBX N/A
  • EPS Growth
  • BHIL N/A
  • UBX N/A
  • EPS
  • BHIL N/A
  • UBX N/A
  • Revenue
  • BHIL $466,725,000.00
  • UBX N/A
  • Revenue This Year
  • BHIL N/A
  • UBX N/A
  • Revenue Next Year
  • BHIL N/A
  • UBX $33.62
  • P/E Ratio
  • BHIL N/A
  • UBX N/A
  • Revenue Growth
  • BHIL 139.60
  • UBX N/A
  • 52 Week Low
  • BHIL $1.86
  • UBX $0.95
  • 52 Week High
  • BHIL $11.03
  • UBX $2.02
  • Technical
  • Relative Strength Index (RSI)
  • BHIL 35.35
  • UBX 26.17
  • Support Level
  • BHIL $1.86
  • UBX $1.10
  • Resistance Level
  • BHIL $3.17
  • UBX $1.23
  • Average True Range (ATR)
  • BHIL 0.38
  • UBX 0.07
  • MACD
  • BHIL 0.10
  • UBX -0.02
  • Stochastic Oscillator
  • BHIL 48.55
  • UBX 4.46

About BHIL Benson Hill Inc.

Benson Hill Inc is an ag-tech company specializing in soy protein innovation. The company has one business segment Ingredient. The company focuses on seed innovation through proprietary germplasm and the CropOS platform. This platform integrates protein, genomic, and strategic data for predictive breeding using AI and ML. They operate a Crop Accelerator for rapid prototyping. Benson Hill is developing a seed portfolio for protein ingredients, aquaculture, specialty animal feed, and vegetable oils. The company's revenue can be disaggregated into product categories: Proprietary and Non-Proprietary. Proprietary revenue is defined as any sale of a proprietary bean. Non-Proprietary revenue is all other revenue from non-Proprietary sources.

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Share on Social Networks: